These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
383 related articles for article (PubMed ID: 28170043)
21. The morphologic spectrum of germline-mutated BAP1-inactivated melanocytic tumors includes lesions with conventional nevic melanocytes: A case report and review of literature. Wysozan TR; Khelifa S; Turchan K; Alomari AK J Cutan Pathol; 2019 Nov; 46(11):852-857. PubMed ID: 31206729 [TBL] [Abstract][Full Text] [Related]
22. Germline BAP1 mutations misreported as somatic based on tumor-only testing. Abdel-Rahman MH; Rai K; Pilarski R; Davidorf FH; Cebulla CM Fam Cancer; 2016 Apr; 15(2):327-30. PubMed ID: 26748926 [TBL] [Abstract][Full Text] [Related]
23. Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature. Haugh AM; Njauw CN; Bubley JA; Verzì AE; Zhang B; Kudalkar E; VandenBoom T; Walton K; Swick BL; Kumar R; Rana HQ; Cochrane S; McCormick SR; Shea CR; Tsao H; Gerami P JAMA Dermatol; 2017 Oct; 153(10):999-1006. PubMed ID: 28793149 [TBL] [Abstract][Full Text] [Related]
24. Analysis of BAP1 Germline Gene Mutation in Young Uveal Melanoma Patients. Cebulla CM; Binkley EM; Pilarski R; Massengill JB; Rai K; Liebner DA; Marino MJ; Singh AD; Abdel-Rahman MH Ophthalmic Genet; 2015 Jun; 36(2):126-31. PubMed ID: 25687217 [TBL] [Abstract][Full Text] [Related]
25. A novel BAP1 mutation is associated with melanocytic neoplasms and thyroid cancer. McDonnell KJ; Gallanis GT; Heller KA; Melas M; Idos GE; Culver JO; Martin SE; Peng DH; Gruber SB Cancer Genet; 2016 Mar; 209(3):75-81. PubMed ID: 26774355 [TBL] [Abstract][Full Text] [Related]
27. [Pathological Diagnosis and Genetic Alterations of Meningioma]. Yuzawa S No Shinkei Geka; 2024 Jul; 52(4):674-683. PubMed ID: 39034506 [TBL] [Abstract][Full Text] [Related]
28. Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations. Kadariya Y; Cheung M; Xu J; Pei J; Sementino E; Menges CW; Cai KQ; Rauscher FJ; Klein-Szanto AJ; Testa JR Cancer Res; 2016 May; 76(9):2836-44. PubMed ID: 26896281 [TBL] [Abstract][Full Text] [Related]
29. Histologically Diverse BAP1-Deficient Melanocytic Tumors in a Patient With BAP1 Tumor Predisposition Syndrome. Louw A; Creaney J; Thomas A; Van Vliet C; Harvey NT; Wood BA; Mesbah Ardakani N Am J Dermatopathol; 2020 Nov; 42(11):872-875. PubMed ID: 32649346 [TBL] [Abstract][Full Text] [Related]
30. WHO grade III meningioma: De novo tumors show improved progression free survival as compared to secondary progressive tumors. Ruzevick J; Gibson A; Tatman P; Emerson S; Ferreira M J Clin Neurosci; 2021 Sep; 91():105-109. PubMed ID: 34373013 [TBL] [Abstract][Full Text] [Related]
31. "Rhabdoid" meningioma: an aggressive variant. Perry A; Scheithauer BW; Stafford SL; Abell-Aleff PC; Meyer FB Am J Surg Pathol; 1998 Dec; 22(12):1482-90. PubMed ID: 9850174 [TBL] [Abstract][Full Text] [Related]
32. Exon scanning for mutations of the NF2 gene in pediatric ependymomas, rhabdoid tumors and meningiomas. Slavc I; MacCollin MM; Dunn M; Jones S; Sutton L; Gusella JF; Biegel JA Int J Cancer; 1995 Aug; 64(4):243-7. PubMed ID: 7657387 [TBL] [Abstract][Full Text] [Related]
33. A recurrent germline BAP1 mutation and extension of the BAP1 tumor predisposition spectrum to include basal cell carcinoma. Wadt KA; Aoude LG; Johansson P; Solinas A; Pritchard A; Crainic O; Andersen MT; Kiilgaard JF; Heegaard S; Sunde L; Federspiel B; Madore J; Thompson JF; McCarthy SW; Goodwin A; Tsao H; Jönsson G; Busam K; Gupta R; Trent JM; Gerdes AM; Brown KM; Scolyer RA; Hayward NK Clin Genet; 2015 Sep; 88(3):267-72. PubMed ID: 25225168 [TBL] [Abstract][Full Text] [Related]
34. Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations. Mochel MC; Piris A; Nose V; Hoang MP Am J Clin Pathol; 2015 Jun; 143(6):901-4. PubMed ID: 25972334 [TBL] [Abstract][Full Text] [Related]
36. Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation. Gerami P; Yélamos O; Lee CY; Obregon R; Yazdan P; Sholl LM; Guitart GE; Njauw CN; Tsao H JAMA Dermatol; 2015 Nov; 151(11):1235-9. PubMed ID: 26154183 [TBL] [Abstract][Full Text] [Related]
37. Rhabdoid transformation of tumor cells in meningiomas: a histologic indication of increased proliferative activity: report of four cases. Kepes JJ; Moral LA; Wilkinson SB; Abdullah A; Llena JF Am J Surg Pathol; 1998 Feb; 22(2):231-8. PubMed ID: 9500225 [TBL] [Abstract][Full Text] [Related]
38. Aggressive rhabdoid meningioma with osseous, papillary and chordoma-like appearance. Karabagli P; Karabagli H; Yavas G Neuropathology; 2014 Oct; 34(5):475-83. PubMed ID: 24702318 [TBL] [Abstract][Full Text] [Related]
39. [Rhabdoid meningioma: a potentially aggressive new variant]. Vajtai I; Pálka I; Varga Z; Mucsi Z; Tarjányi J; Horváth K; Bodosi M Orv Hetil; 2000 May; 141(19):1025-30. PubMed ID: 10846425 [TBL] [Abstract][Full Text] [Related]
40. Molecular pathogenesis of meningiomas. Perry A; Gutmann DH; Reifenberger G J Neurooncol; 2004 Nov; 70(2):183-202. PubMed ID: 15674477 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]